Venu Holding Corporation ("VENU" or the "Company") (NYSE AMERICAN: VENU), owner and developer of premium live entertainment destinations, today announced executive leadership appointments that ...
12h
SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback